Nona Biosciences logo — Empower Global Biotherapeutic Innovation

Nona Biosciences

Empower Global Biotherapeutic Innovation

Founded 2022 United States Cambridge, United States 37 employees

General Information

Company Name Nona Biosciences
Founded Year 2022
Location United States Cambridge, United States +1
Employees 37
Social

Get notified when Nona Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nona Biosciences

Nona Biosciences is a global biotechnology company established in 2022, headquartered in the United States. The company's mission revolves around empowering global biotherapeutic innovation and offering a comprehensive solution for partners worldwide, spanning from academies and biotech startups to biopharma giants. Nona Biosciences specializes in integrated antibody discovery services, covering antigen preparation, animal immunization, single B cell screening, antibody lead generation and engineering, developability assessment, and pharmacological evaluation. The company leverages the strengths of its proprietary Harbour Mice® platforms and a seasoned therapeutic antibody discovery team. The groundbreaking Harbour Mice® technology is capable of producing fully human monoclonal antibodies in two heavy and two light chains (H2L2) format, as well as heavy chain only (HCAb) format. Furthermore, integrating Harbour Mice® and a single B cell cloning platform, Nona Biosciences prioritizes driving global inventions of transformative next-generation drugs through diversified partnership strategies, including co-discovery, platform and antibody discovery, and platform license. The company's credibility is underlined by its successful collaborations with over 50 industry and academic partners across 200 projects. Nona Biosciences' commitment to revolutionizing the biotechnology landscape and fostering global innovation positions it as an attractive prospect for potential investors seeking to capitalize on the burgeoning biopharma sector and cutting-edge antibody discovery platforms.

Taxonomy: antibody discovery, therapeutic antibodies, biotherapeutic innovation, transgenic mouse platforms, biopharma, biologic drug discovery, partnership strategies, pharmacological evaluation, transformative drugs, HBM Holdings Limited, Modern, global inventions, antigen preparation, flexible partnership models

No funding data available for Nona Biosciences yet.

Get notified when Nona Biosciences raises funding

Nona Biosciences Alternatives & Competitors

Nona Biosciences vs
Harbour BioMed
Harbour BioMed United States

Healthy Life · Breakthrough Medicines

IPO
113 employees
Biopharma, Biotechnology
Nona Biosciences vs

Transforming Immunotherapy with Precision

Undisclosed
18 employees
Biotechnology
Nona Biosciences vs
Yumab GmbH
Yumab GmbH Germany

From Target to Lead

20 employees
Biotechnology, Health and Wellness

FAQ About Nona Biosciences

Empower Global Biotherapeutic Innovation
Nona Biosciences was founded in 2022.
Nona Biosciences is headquartered in Cambridge, United States.
Nona Biosciences has approximately 37 employees.
Top alternatives and competitors to Nona Biosciences include Harbour BioMed, Elixiron Immunotherapeutics, Yumab GmbH, OSE Immunotherapeutics, Federation Equestre Internationale (FEI). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nona Biosciences and Harbour BioMed are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nona Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy